Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Neuropsychopharmacol Hung ; 15(2): 105-17, 2013 Jun.
Article in Hungarian | MEDLINE | ID: mdl-23817361

ABSTRACT

When treating schizophrenia and other psychotic disorders, clinicians often encounter the problems of non-adherence, which is almost the most common drawback of achieving remission and a better quality of life. The uncertain oral drug taking habits may lead to relapses and rehospitalizations. Using second generation long acting injectables we have more possibilities to avoid these problems. This review attempts to present and describe the pharmacological background of the modern long acting injectables including patient cases where olanzapine pamoate long acting injectable provided remission and better quality of life for the patients.


Subject(s)
Antipsychotic Agents/therapeutic use , Benzodiazepines/therapeutic use , Medication Adherence , Psychotic Disorders/drug therapy , Psychotic Disorders/psychology , Administration, Oral , Adult , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/adverse effects , Benzodiazepines/administration & dosage , Benzodiazepines/adverse effects , Delayed-Action Preparations/therapeutic use , Female , Humans , Hypnotics and Sedatives/adverse effects , Injections, Intramuscular , Male , Middle Aged , Olanzapine , Psychotic Disorders/diagnosis , Recurrence , Schizophrenia/drug therapy , Schizophrenic Psychology
SELECTION OF CITATIONS
SEARCH DETAIL
...